TLSA News and Press, Tiziana Life Sciences plc From 08/11/25

NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human...

2025-08-07 08:00:00 ET The following segment was excerpted from the The Nightview Fund Q2 2025 Letter. In July, Tesla ( TLSA ) flipped the switch. Its robotaxi network—powered by the company’s Full Self-Dr...

SOPHiA GENETICS SA (SOPH) is expected to report for Q2 2025 Investors Title Company (ITIC) is expected to report for Q2 2025 Safehold Inc. (SAFE) is expected to report $0.39 for Q2 2025 First Guaranty Bancshares Inc. (FGBI) is expected to report $-0.2 for Q2 2025 United Fire Group...

NEW YORK, July 21, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human...

2025-07-05 08:05:00 ET Happy (belated) Independence Day to my fellow Americans! As we celebrate freedom, let us also celebrate whatever progress we have made on our respective journeys to financial freedom. My hope is that this article will help you with that journey, wherever you f...

2025-07-03 13:39:12 ET More on NVIDIA, Apple, etc. Why Dell Is The Undervalued AI Giant You Can't Afford To Ignore Nvidia: OpenAI-AMD Partnership Implications Dell: Outstanding Cash Flows And Impressive Backlog - Reiterate Buy CoreWeave becomes first hypersca...

2025-06-22 18:46:50 ET Tiziana Life Sciences Ltd (TLSA) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 1.57%. The average open to low on the day of earnings was -5.46%. The average open...

2025-06-22 18:41:50 ET Tiziana Life Sciences Ltd (TLSA) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in TLSA stock price following earnings has averaged ±3.18% , with a median of 2.32%...

2025-06-13 23:08:15 ET The last time I spoke about Tiziana Life Sciences ( TLSA ) it was with respect to a Seeking Alpha article entitled "Tiziana: Foralumab Drug Development Presses On With Additional EAP Enrollment". With respect to this article, I noted that the company was w...

NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human...